Detalles de la búsqueda
1.
Peg-interferon alpha add-on Tenofovir disoproxil fumarate achieved more HBsAg loss in HBeAg-positive chronic hepatitis B naïve patients.
J Viral Hepat
; 28(10): 1381-1391, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34228855
2.
Comparison of Serum Hepatitis B Virus RNA Levels and Quasispecies Evolution Patterns between Entecavir and Pegylated-Interferon Mono-treatment in Chronic Hepatitis B Patients.
J Clin Microbiol
; 58(9)2020 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32554476
3.
Serum M2BPGi level is a novel predictive biomarker for the responses to pegylated interferon-α treatment in HBeAg-positive chronic hepatitis B patients.
J Med Virol
; 90(4): 721-729, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29247529
4.
Glucose-sensitive polyelectrolyte nanocapsules based on layer-by-layer technique for protein drug delivery.
J Mater Sci Mater Med
; 25(1): 121-9, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24068543
5.
Quantitative hepatitis B surface antigen combined with hepatitis B e antigen as sustained virological response predictors during extended therapy with Peginterferon alfa-2a for hepatitis B e antigen-positive chronic hepatitis B.
J Clin Virol
; 72: 88-94, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26476325
6.
Early serum hepatitis B virus large surface protein level: a stronger predictor of virological response to peginterferon alfa-2a than that to entecavir in HBeAg-positive patients with chronic hepatitis B.
J Clin Virol
; 57(4): 318-22, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23639294
7.
Phenylboronic acid grafted chitosan as a glucose-sensitive vehicle for controlled insulin release.
J Pharm Sci
; 100(6): 2278-86, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21268025
Resultados
1 -
7
de 7
1
Próxima >
>>